Literature DB >> 20346386

Clostridial neurotoxins as a drug delivery vehicle targeting nervous system.

Bal Ram Singh1, Nagarajan Thirunavukkarasu, Koyel Ghosal, Easwaran Ravichandran, Roshan Kukreja, Shuowei Cai, Peng Zhang, Radharaman Ray, Prabhati Ray.   

Abstract

Several neuronal disorders require drug treatment using drug delivery systems for specific delivery of the drugs for the targeted tissues, both at the peripheral and central nervous system levels. We describe a review of information currently available on the potential use of appropriate domains of clostridial neurotoxins, tetanus and botulinum, for effective drug delivery to neuronal systems. While both tetanus and botulinum neurotoxins are capable of delivering drugs the neuronal cells, tetanus neurotoxin is limited in clinical use because of general immunization of population against tetanus. Botulinum neurotoxin which is also being used as a therapeutic reagent has strong potential for drug delivery to nervous tissues. Copyright (c) 2010. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20346386     DOI: 10.1016/j.biochi.2010.03.005

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  12 in total

1.  In Vivo Toxicity and Immunological Characterization of Detoxified Recombinant Botulinum Neurotoxin Type A.

Authors:  Easwaran Ravichandran; Pavithra Janardhanan; Kruti Patel; Stephen Riding; Shuowei Cai; Bal Ram Singh
Journal:  Pharm Res       Date:  2015-11-03       Impact factor: 4.200

2.  Neuronal delivery of antibodies has therapeutic effects in animal models of botulism.

Authors:  Patrick M McNutt; Edwin J Vazquez-Cintron; Luis Tenezaca; Celinia A Ondeck; Kyle E Kelly; Mark Mangkhalakhili; James B Machamer; Christopher A Angeles; Elliot J Glotfelty; Jaclyn Cika; Cesar H Benjumea; Justin T Whitfield; Philip A Band; Charles B Shoemaker; Konstantin Ichtchenko
Journal:  Sci Transl Med       Date:  2021-01-06       Impact factor: 17.956

3.  Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.

Authors:  Padmamalini Baskaran; Teresa E Lehmann; Elena Topchiy; Nagarajan Thirunavukkarasu; Shuowei Cai; Bal Ram Singh; Sharad Deshpande; Baskaran Thyagarajan
Journal:  Toxicon       Date:  2013-06-25       Impact factor: 3.033

4.  The receptor binding domain of botulinum neurotoxin serotype A (BoNT/A) inhibits BoNT/A and BoNT/E intoxications in vivo.

Authors:  Alon Ben David; Eran Diamant; Ada Barnea; Osnat Rosen; Amram Torgeman; Ran Zichel
Journal:  Clin Vaccine Immunol       Date:  2013-06-12

Review 5.  Botulinum toxin: bioweapon & magic drug.

Authors:  Ram Kumar Dhaked; Manglesh Kumar Singh; Padma Singh; Pallavi Gupta
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

Review 6.  Towards new uses of botulinum toxin as a novel therapeutic tool.

Authors:  Andy Pickett; Karen Perrow
Journal:  Toxins (Basel)       Date:  2011-01-12       Impact factor: 4.546

7.  Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.

Authors:  Sabine Pellett; William H Tepp; Jacob M Scherf; Eric A Johnson
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

8.  Production and characterization of recombinant light chain and carboxyterminal heavy chain fragments of tetanus toxin.

Authors:  Mehdi Yousefi; Roya Khosravi-Eghbal; Azam Hemmati; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2013-10

9.  Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm.

Authors:  Edwin J Vazquez-Cintron; Maksim Vakulenko; Philip A Band; Larry H Stanker; Eric A Johnson; Konstantin Ichtchenko
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol.

Authors:  Benjamin J Pavlik; Elizabeth J Hruska; Kevin E Van Cott; Paul H Blum
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.